Jay P. Garg

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate‐to‐Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

M. Genovese, A. Kivitz, J. Garg, 2017, Arthritis & rheumatology.